AbbVie Sues Amgen to Fend Off Copy of Blockbuster HumiraBy and
Drugmaker claims Amgen’s proposed copy infringes 10 patents
AbbVie says it has 51 other patents for arthritis medicine
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.